Cita APA

C, C., M, R., A, S., A, N., S, F., M, V., . . . A, P. (2019). Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: A Phase II Pilot Study.

Citación estilo Chicago

C, Casasnovas, et al. Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: A Phase II Pilot Study. 2019.

Cita MLA

C, Casasnovas, et al. Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: A Phase II Pilot Study. 2019.